Abstract
Objective
The objective was to report a severe skin reaction, erythema multiforme major, following administration of docetaxel.
Case summary
A female patient receiving weekly docetaxel for metastatic breast cancer developed a severe skin reaction characterized by blistering target lesions on her upper and lower extremities as well as painful ulcers of her oropharynx. The diagnosis of erythema multiforme major was made and high-dose hydrocortisone began, with gradual resolution of her symptoms.
Discussion
The semi-synthetic taxoid docetaxel, which is increasingly being used in the treatment of breast cancer, has been associated with several adverse skin reactions, including hypersensitivity, nail pigmentation, nail onycholysis, erythrodysethesia, and scleroderma. We report the first case of erythema multiforme major (Stevens-Johnson syndrome) following docetaxel. Erythema multiforme major is a rare inflammatory skin disease associated with certain drugs (i.e., sulfonamides, non-steroidal anti-inflammatory agents, anticonvulsants). It is characterized by a distinguishing target skin lesion and ulceration of mucosal surfaces. In severe cases, systemic manifestations such as pneumonitis can also occur. Treatment involves use of moderate to high-dose corticosteroids.
Summary
Clinicians using docetaxel should be aware of the variety of skin reactions that can occur, how they can be avoided and their severity reduced. Severe skin reactions such as occurred with our patient should be recognized and treated promptly in consultation with a dermatologist.
Similar content being viewed by others
References
Aventis Pharmaceuticals (2000) Taxotere prescribing information. Aventis Pharmaceuticals, Collegeville
Correia O, Azevedo C, Pinto Ferreira E, Braga Cruz F, Polonia J (1999) Nail changes secondary to docetaxel (taxotere). Dermatology 198:288–290
Eich D, Scharffetter-Kochanek K, Eich HT, Tantcheva-Poor I, Krieg T (2002) Acral erythrodysesthesia syndrome caused by intravenous infusion of docetaxel in breast cancer. Am J Clin Oncol 25:599–602
Hassett G, Harnett P, Manolios N (2001) Scleroderma in association with the use of docetaxel (taxotere) for breast cancer. Clin Exp Rheumatol 19:197–200
Various (2001) Cutaneous drug reaction case reports from the world literature. Am J Clin Dermatol 12:267–274
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moisidis, C., Möbus, V. Erythema multiforme major following docetaxel. Arch Gynecol Obstet 271, 268–270 (2005). https://doi.org/10.1007/s00404-004-0643-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-004-0643-9